Corrigendum: miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma (International Journal of Oncology (2015) 46 (2163-2171) DOI: 10.3892/ijo.2015.2900);miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma

International Journal of Oncology

Volumn 46, Issue 5, 2015, Pages 2163-2171

  Yang, Xuan ^a   Zang, Wenqiao ^a   Xuan, Xiaoyan ^a   Wang, Zhongquan ^a   Liu, Zhicai ^b   Wang, Jinwu ^b   Cui, Jing ^a   Zhao, Guoqiang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Department of Oncology   (China)

Author keywords

Apoptosis; Esophageal carcinoma; Invasion; miRNA 1207 5p; Stomatin like protein 2

Indexed keywords

MICRORNA; MICRORNA 1207 5P; STOMATIN; STOMATIN LIKE PROTEIN 2; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MIRN1207 MICRORNA, HUMAN; PLASMA PROTEIN; STOML2 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER GROWTH; CANCER TISSUE; CELL DIFFERENTIATION; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN TARGETING; WESTERN BLOTTING; AGED; BIOSYNTHESIS; DISEASE COURSE; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADULT; AGED; APOPTOSIS; BLOOD PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84925450541     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2018.4254     Document Type: Erratum

References (39)

1. Lee RC and Ambros V: An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864, 2001.
2. Lau NC, Lim LP, Weinstein EG and Bartel DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862, 2001.
3. Ambros V: microRNAs: Tiny regulators with great potential. Cell 107: 823-826, 2001.
4. Hede K: Studies define role of microRNA in cancer. J Natl Cancer Inst 97: 1114-1115, 2005.
5. Cheng T, Hu C, Yang H, Cao L and An J: Transforming growth factor-β-induced miR-143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo. Int J Oncol 45: 1977-1988, 2014.
6. Chiyomaru T, Seki N, Inoguchi S, et al: Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. Int J Oncol 46: 487-496, 2015.
7. Pei J, Robu V, Feder M, Cheung M, Neumann-Domer E, Talarchek J, Dulaimi E, Millenson MM and Testa JR: Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma. Cancer Genet 207: 98-102, 2014.
8. Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, Wang T and Zhao G: MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol Dordr 36: 385-394, 2013.
9. Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, Zhao ZG and Yang K: MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: Potential biomarkers and therapeutic targets. Cell Prolif 47: 277-286, 2014.
10. Chen Z, Li J, Tian L, et al: MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma. Cancer Lett 350: 34-42, 2014.
11. Peña-Chilet M, Martínez MT, Pérez-Fidalgo JA, et al: MicroRNA profile in very young women with breast cancer. BMC Cancer 14: 529, 2014.
12. Mun J, Tam C, Chan G, Kim JH, Evans D and Fleiszig S: MicroRNA-762 is upregulated in human corneal epithelial cells in response to tear fluid and Pseudomonas aeruginosa antigens and negatively regulates the expression of host defense genes encoding RNase7 and ST2. PLoS One 8: e57850, 2013.
13. Chen L, Lü MH, Zhang D, et al: miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telom-erase reverse transcriptase. Cell Death Dis 5: e1034, 2014.
14. Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y, Pierides A, Gretz N, Felekkis KN and Deltas C: A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PLoS One 7: e31021, 2012.
15. Alvarez ML, Khosroheidari M, Eddy E and Kiefer J: Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: Implications for diabetic nephropathy. PLoS One 8: e77468, 2013.
16. Wang Y and Morrow JS: Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem 275: 8062-8071, 2000.
17. Owczarek CM, Treutlein HR, Portbury KJ, Gulluyan LM, Kola I and Hertzog PJ: A novel member of the STOMATIN/EPB72/mec-2 family, stomatin-like 2 (STOML2), is ubiquitously expressed and localizes to HSA chromosome 9p13.1. Cytogenet Cell Genet 92: 196-203, 2001.
18. Lapatsina L, Brand J, Poole K, Daumke O and Lewin GR: Stomatin-domain proteins. Eur J Cell Biol 91: 240-245, 2012.
19. Liu Z, Yang Y, Zhang Y, Ye X, Wang L and Xu G: Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF- β in thyroid cancer cells. Oncol Rep 31: 153-160, 2014.
20. Cao W, Zhang B, Liu Y, et al: High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol 128: 430-436, 2007.
21. Cui Z, Zhang L, Hua Z, Cao W, Feng W and Liu Z: Stomatin-like protein 2 is overexpressed and related to cell growth in human endometrial adenocarcinoma. Oncol Rep 17: 829-833, 2007.
22. Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, Wu Y, Li W, Li Y and Liu Z: Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res 12: 1639-1646, 2006.
23. Cao W, Zhang B, Li J, Liu Y, Liu Z and Sun B: SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer. Pathology 43: 713-718, 2011.
24. Cao W, Zhang B, Ding F, Zhang W, Sun B and Liu Z: Expression of SLP-2 was associated with invasion of esophageal squamous cell carcinoma. PLoS One 8: e63890, 2013.
25. Song L, Liu L, Wu Z, Lin C, Dai T, Yu C, Wang X, Wu J, Li M and Li J: Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway. J Pathol 226: 534-543, 2012.
26. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
27. Adams BD, Kasinski AL and Slack FJ: Aberrant regulation and function of microRNAs in cancer. Curr Biol 24: R762-R776, 2014.
28. Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM and Ghobrial IM: Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta 1845: 255-265, 2014.
29. Chang D, Ma K, Gong M, Cui Y, Liu ZH, Zhou XG, Zhou CN and Wang TY: SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma. Biomarkers 15: 104-110, 2010.
30. Gasparini C, Celeghini C, Monasta L and Zauli G: NF-kappaB pathways in hematological malignancies. Cell Mol Life Sci 71: 2083-2102, 2014.
31. Tong L, Yuan Y and Wu S: Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers. Adv Drug Deliv Rev 81: 1-15, 2015.
32. Abdel-Latif MM, O'Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D and Reynolds JV: NF-kappaB activation in esophageal adenocarcinoma: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 239: 491-500, 2004.
33. Gong H, Song L, Lin C, Liu A, Lin X, Wu J, Li M and Li J: Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res 19: 1083-1093, 2013.
34. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27: 5643-5647, 2008.
35. Kumar V, Palermo R, Talora C, et al: Notch and NF-κB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia. Leukemia 28: 2324-2335, 2014.
36. Hardwick JM, Chen YB and Jonas EA: Multipolar functions of BCL-2 proteins link energetics to apoptosis. Trends Cell Biol 22: 318-328, 2012.
37. Wood WG, Igbavboa U, Muller WE and Eckert GP: Statins, Bcl-2, and apoptosis: Cell death or cell protection? Mol Neurobiol 48: 308-314, 2013.
38. Sarbia M, Bittinger F, Porschen R, Verreet P, Dutkowski P, Willers R and Gabbert HE: bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus. Int J Cancer 69: 324-328, 1996.
39. Torzewski M, Sarbia M, Heep H, Dutkowski P, Willers R and Gabbert HE: Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Clin Cancer Res 4: 577-583, 1998.